Next generation

full-body embolic
protection for TAVI

Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device

Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications.

READ MORE

FILTERLEX

Our goal is to develop the next generation embolic protection device to reduce the risk of stroke and other complications during catheter-based structural heart procedures. The CAPTIS® concept and unique structure was created out of deep understanding and knowledge of the TAVI procedure and the unmet need.

THE NEED

During catheter-based, left-heart procedures such as TAVI, embolic particles are often released to the blood flow. Particles migration to the brain may cause a spectrum of neurological deficiencies, from cognitive impairment to debilitating stroke. Emboli released to distal organs may result in acute kidney injury and ischemia.

CAPTIS®

The CAPTIS® is a next-generation full-body embolic protection device, easily and intuitively deployed and retrieved. The device is securely positioned in the aorta, protects its surface while facilitating a seamless TAVI procedure. Its distinctive, triple action design provides a full-body embolic protection by deflecting, capturing and removing embolic particles. Uniquely, it requires no additional access and does not interfere to the procedure workflow.

CAPTIS® UNIQUE BENEFITS

Full-body embolic protection

Embolic capture and extraction

Easy and intuitive deployment and retrieval

Aortic surface protection

Fully integrates with the procedure

No interference to procedure devices

Stable and safe anchoring

Very stable aortic arch deflector

Accommodates anatomical variations

NEWS

Filterlex Medical Announces Positive Results from A First-In-Human Study for the CAPTIS® Full-Body Embolic Protection Device

June 2 - 2022

Cardiovascular data presented at EuroPCR 2022 demonstrates successful device performance during a TAVR procedure with no complications.

Filterlex Medical Successfully Completes First-In-Human Study for CAPTIS® Full-Body Embolic Protection Device

May 10 - 2022

Cardiovascular study results to be presented by Prof. Ran Kornowski, Director of the Cardiology Center, Rabin Medical Center at the EuroPCR 2022 conference in May

Read more >> 

Cardiovascular Startup, Filterlex Medical, Selected to Receive €7M from the European Innovation Council

Dec 21 - 2021

Equity investment to support advancement of its breakthrough full-body embolic protection device to reduce the risk of stroke and other complications during left-heart procedures.

Read more >> 

Filterlex Medical Closes a $6Million Series A1 Investment to Accelerate the CAPTIS® Cardiovascular Clinical Program

Nov 18 - 2021

The financing will accelerate implementation of the company’s CAPTIS® clinical program

Read more >> 

Update on Cerebral Embolic Protection by Mary Stuart. MedTech Strategist.

July-August 2021 - Vol. 8, No. 7.

Deflection and Capture Provides Full-Body Protection.

Read more >> 

The European Commission Horizon 2020 Program Backs Filterlex’s Embolic Protection Device - CAPTIS

Sep 16 - 2019

€2.1M Grant to support Filterlex’s CAPTIS clinical trials

Read more >> 

Best Innovation Award at the EuroPCR

May 6 - 2019

Filterlex receives the Best Innovation Award at the EuroPCR 2019 for the CAPTIS Embolic Protection Device for TAVI.

Read more: https://www.jondehaanfoundation.org/award-2019

THE TEAM

Sigal pic for web

Sigal Eli

Inventor, Founder & CEO

Eyal Teichman

Founder & CTO

Giora Weisz, MD

Founder & Chairman of Advisory Board

Tali Amir-Azulay

VP Clinical Affairs

Avi Hillel

VP Operations
Yoav-bw 237x237 (2)

Yoav Mezape

R&D Manager

Dr. Shimon Eckhouse​

Chairman​

Dr. Judith Zilberstein

Director

Ron Davidson

Founder & Active Board Member

This project has received funding from the European Union’s Horizon 2020
research and innovation programme under grant agreement No 881076

filterlex 2019 © All rights reserved
face 2 face – web development

Sigal Eli

Inventor, Founder & CEO

Sigal is an Interventional cardiology imaging expert with extensive experience in TAVR and other catheter-based procedures including EP, LAAC and PCI. She served as a clinical and training specialist at Paieon Medical and supported over 300 TAVR procedures in 20 medical centers worldwide. Sigal also brings extensive experience as a Marketing Communications Manager. Sigal is the inventor of Filterlex’ patent.

Eyal Teichman

Founder & CTO

Eyal is a seasoned entrepreneur and CTO of several medical device start-ups. He is a mechanical engineer with over 30 years of R&D experience, 15 of them in implantable devices in the cardiovascular field. Eyal serves as the CTO of Sil Vascular and Cologuard and previously held senior R&D positions at Labcoat, Cappella, Talia Technology, Celtronix and Orbotech. Eyal holds a BSc in Mechanical Engineering from Ben Gurion University.

Giora Weisz, MD

Founder & Chairman of Advisory Board

Interventional Cardiologist at Columbia University in New York, NY. Previously, Director of Interventional Cardiology at Montefiore Medical Center, and faculty of the Cardiovascular Research Foundation in New York, NY. An internationally recognized researcher focused on innovative technologies in cardiovascular medicine. Pioneered the use of novel robotic-enhanced interventions, including navigation and positioning technologies. Has been the Principal Investigator for pivotal clinical studies leading to FDA approval of cutting-edge technologies.

Tali Amir-Azulay

VP Clinical Affairs

Clinical research professional with over 20 years of experience in the pharmaceutical and medical device industries leading all aspects of phase I, II and III registrational clinical trials in a global environment. Expertise across various indications.

Previously served as Manager of Biometrics and Clinical Operations at Sol-Gel Ltd, during which she took a substantial part in 2 NDA submissions. Tali also served as Director of Biometrics and Clinical Operations at NeuroDerm Ltd. and held leading clinical operations positions at several Israeli start-up companies.

Tali holds an M.A. in Experimental Psychology from Bar-Ilan University, and B.A. in Psychology from Ludwig-Maximilians University, Munich, Germany. Additionally, Tali served as an adjunct lecturer for Data Analysis methods at the Bar-Ilan University and was a member of the managing committee of the Israeli Association for the Advancement of the Biomedical Research Community.

Avi Hillel

VP Operations

Avi has over 20 years of experience in the medical device industry.
He has successfully managed multi-disciplinary global-operations teams for companies the likes of Nyxoah SA and Align Technologies, as well as for several medical device startup companies. Avi holds a B.S. in mechanical engineering from Ben-Gurion University of the Negev and an MA in Industrial Management from Bar-Ilan University.

Yoav Mezape

R&D Manager

Yoav has over 16 years of experience in the medical device industry, with extensive experience in mechanical implants, delivery systems and catheters. Prior to joining Filterlex in 2018, Yoav served as R&D Manager at Nitiloop leading the design and development of the NovaCross™ micro-catheter for CTO treatment in the coronary and peripheral arteries. At Endospan Yoav served in several roles including V&V manager and Horizon Project Manager. Yoav holds a BSc in Biomedical Engineering and Mechanical Engineering from the Technion.

Dr. Shimon Eckhouse

Chairman

Dr. Eckhouse, one of Israel’s leading medical entrepreneurs, is the owner of Alon MedTech Ventures incubator. He takes an active role in choosing projects and accompanying portfolio companies to success by being involved in the technological and business aspects of the portfolio companies. Dr. Eckhouse has founded and invested in numerous medical technology firms, two of which are leading international companies, (ESC Medical [Lumenis] and Syneron Medical), both traded on NASDAQ.

Dr. Judith Zilberstein

Director

Dr. Zilberstein has more than 20 years’ experience in the medical device industry; Vast experience in investments in the Healthcare and nanotech fields. As CEO and CTO at Alon MedTech Ventures, her activities include choosing projects, advancing them into companies and guiding their scientific activity. Further, she assists in structuring marketing strategy and forges scientific and commercial ties with external groups.

Ron Davidson

Founder and Active Board Member

Ron has 20 years of experience in managing and accelerating companies in the healthcare field. He led two companies from early stage to successful acquisitions by multinational companies. Ron previously served as the CEO of Flight Medical, Paieon Medical, Medtechnica Hi-Tech and NexSig and was the senior VP of sales and operations of Medcon, acquired by McKesson. Ron holds a BSc in Mathematics and Computer Sciences and an MBA from Tel-Aviv University.